Журнал "Креативная хирургия и онкология" №3 2010

ОБЗОР ЛИТЕРАТУРЫКреативная хирургия и онкология 91esis in gastrointestinal tract malignancy // Br J Cancer.– 2003. – Vol. 89. – P. 426–430.8. Enholm B., Karpanen T., Jeltsch M. et al. Adenoviralexpression of vascular endothelial growth factorCinduces lymphangiogenesis in the skin // Circ Res 2001.- Vol. 88. – P. 623–629.9. Evangelou E., Kyzas P.A., Trikalinos T.A. Comparisonof the diagnostic accuracy of lymphatic endotheliummarkers: Bayesian approach // Mod Pathol.– 2005. – Vol. 18. – P. 1490–1497.10. Facchetti F., Monzani E., La Porta C.A..New perspectivesin the treatment of melanoma: antiangiogenicand antilymphangiogenic strategies // Recent PatentsAnticancer Drug Discov. – 2007. - №2. – Р.73–78.11. Farnsworth R.H., Achen M.G., Stacker S.A. Lymphaticendothelium: an important interactive surfacefor malignant cells // Pulm Pharmacol Ther. - 2006.- №19. - Р. 51–60.12. Filaci G., Fenoglio D., Fravega M. et al. CD8+Tregulatory lymphocytes inhibiting T cell proliferativeand cytotoxic functions infiltrate human cancers // JImmunol. – 2007. – Vol. 179. – P. 4323–4334.13. Garmy-Susini B., Makale M., Fuster M., VarnerJ.A. Methods to study lymphatic vessel integrins //Methods Enzymol. – 2007. – Vol. 426. – P. 415–438.14. Gunther K., Leier J., Henning G. et al. Predictionof lymph node metastasis in colorectal carcinoma byexpression of chemokine receptor CCR7 // Int J Cancer2005. - Vol. 116. – P. 726–733.15. He Y., Rajantie I., Pajusola K. el al. Vascular endothelialcell growth factor receptor 3mediated activationof lymphatic endothelium is crucial for tumor cellentry and spread via lymphatic vessels // Cancer Res.– 2005. – Vol. 65. - P. 4739–4746.16. Heckman C.A., Holopainen T., Wirzenius M. etal. The tyrosine kinase inhibitor cediranib blocks ligandinducedvascular endothelial growth factor receptor3activity and lymphangiogenesis // Cancer Res. – 2008.– Vol. 68. - P. 4754–4762.17. Huang X.Z., Wu J.F., Ferrando R. et al. Fatal bilateralchylothorax in mice lacking the integrin alpha9beta1// Mol Cell Biol. - 2000. - №20. – Р. 5208–5215.18. Ji R.C., Kato S. Lymphatic network and lymphangiogenesisin the gastric wall // J Histochem Cytochem.– 2003. – Vol. 51. – P. 331–338.19. Joukov V., Pajusola K., Kaipainen A. et al. A novelvascular endothelial growth factor, VEGFC, is a ligandfor the Flt4 (VEGFR3) and KDR (VEGFR2) receptor tyrosinekinases // EMBO J. - 1996. - № 15. – Р. 290–298.20. Kaiserling E., Krober S., Geleff S. Lymphaticvessels in the colonic mucosa in ulcerative colitis //Lymphology. – 2003. – Vol. 36. – P. 52–61.21. Karpanen T., Heckman C.A., Keskitalo S. etal. Functional interaction of VEGFC and VEGFD withneuropilin receptors // FASEB J. – 2006. - №20. –Р. 1462–1472.22. Kaushal V., Mukunyadzi P., Dennis R.A. et al.Stagespecific characterization of the vascular endothelialgrowth factor axis in prostate cancer: expression oflymphangiogenic markers is associated with advancedstagedisease // Clin Cancer Res. – 2005. - №11. –Р. 584–593.23. Kimura H., Kato H., Tanaka N. et al. Preoperativeserum vascular endothelial growth factorC(VEGFC) levels predict recurrence in patients with esophagealcancer // Anticancer Res. – 2008. – Vol. 28.– P. 165–169.24. Koukourakis M.I., Giatromanolaki A., Sivridis E.et al. LYVE1 immunohistochemical assessment of lymphangiogenesisin endometrial and lung cancer // J ClinPathol. – 2005. – Vol. 58. – P. 202–206.25. Krishnan J., Kirkin V., Steffen A. et al. Differentialin vivo and in vitro expression of vascular endothelialgrowth factor (VEGF)C and VEGFD in tumors andits relationship to lymphatic metastasis in immunocompetentrats // Cancer Res. – 2003 – Vol. 63. – P.713–722.26. Krzystek-Korpacka M., Matusiewicz M., DiakowskaD. et al. Upregulation of VEGFC secreted bycancer cells and not VEGFA correlates with clinicalevaluation of lymph node metastasis in esophageal squamouscell carcinoma (ESCC) // Cancer Lett. – 2007.– Vol. 249. – P. 171–177.27. Kuroda K., Horiguchi A., Asano T. et al. Predictionof lymphatic invasion by peritumoral lymphaticvessel density in prostate biopsy cores // Prostate. –2008. – Vol. 68. - P. 1057–1063.28. Kyzas P.A., Geleff S., Batistatou A. et al. Evidencefor lymphangiogenesis and its prognostic implicationsin head and neck squamous cell carcinoma // JPathol. - 2005. – Vol. 206. – Р. 170-177.29. Lee J.H. et al. Quantitative analysis of melanomainducedcytokinemediated immunosuppression inmelanoma sentinel nodes // Clin Cancer Res. – 2005.- №11. – Р. 107–112.30. Li Q., Dong X., Gu W. et al. Clinical significanceof coexpression of VEGFC and VEGFR3 in nonsmallcell lung cancer. Chin Med J (Engl). – 2003. – Vol. 116.– P. 727–730.31. Loges S., Clausen H., Reichelt U. et al. Determinationof microvessel density by quantitative realtimePCR in esophageal cancer: correlation with histologicmethods, angiogenic growth factor expression, andlymph node metastasis // Clin Cancer Res. – 2007.– Vol. 13. – P. 76–80.32. Makinen T., Jussila L., Veikkola T. et al. Inhibitionof lymphangiogenesis with resulting lymphedemain transgenic mice expressing soluble VEGF receptor3// Nat Med. – 2001. - № 7. – Р. 199–205.33. Makinen T., Veikkola T., Mustjoki S. et al. Isolatedlymphatic endothelial cells transduce growth, survivaland migratory signals via the VEGFC/D receptorVEGFR3 // EMBO J. – 2001. - №20. – Р. 4762–4773.34. Maruyama K., Ii M., Cursiefen C. et al.Inflammationinduced lymphangiogenesis in the corneaarises from CD11bpositive macrophages // J Clin Invest.– 2005. – Vol. 115. – P. 2363–2372.35. Muller A., Homey B., Soto H. et al. Involvementof chemokine receptors in breast cancer metastasis //Nature. - 2001. - Vol. 410. – P. 50–56.36. Nagy J.A., Vasile E., Feng D. et al. Vascular permeabilityfactor/vascular endothelial growth factor induceslymphangiogenesis as well as angiogenesis // JExp Med. – 2002. – Vol. 196. – P. 1497–1506.